Why Infectious Disease Matters

Infectious diseases know no borders. Increased air travel, international trade, urbanization and environmental changes all open up the world’s population to outbreaks of old communicable diseases and emergence of new ones. At the same time, disease microbes are becoming more resistant, so some of the medicines traditionally used to treat them have become less effective. An outbreak in one country can rapidly spread, affecting developing and industrialized nations alike, making disease surveillance and containment increasingly critical.

Current Research

UNC-Chapel Hill has enormous global strengths in tracking, preventing and controlling both diseases like malaria, tuberculosis, and AIDS, as well as recently emerging diseases like avian influenza and SARS. UNC is ranked in the top ten of all United States HIV/AIDS programs, and our discoveries have made global headlines and won awards such as the “Scientific Breakthrough of the Year” award by the journal Science. UNC’s Institute for Global Health and Infectious Diseases, is a pan-university Institute that was created to unify and bolster global health research, teaching, and service across UNC-Chapel Hill.

Additional Research in the Field of Infectious Disease

TB still major public health threat in China due to knowledge-practice gap, study finds

Gillings Professor Ralph Baric answers questions about how prepared we are for the next pandemic

Too few pre-teens receive recommended vaccinations, especially for HPV

New drug holds potential to defeat coronaviruses

NIAID renews 5-year grant for research on emerging viruses

More treatment options needed for HIV-positive women with cervical dysplasia, study finds

New study investigates perceptions, ethics of treatment interruptions in HIV cure research

Gillings researchers find further evidence that bats may be evolutionary source of MERS


Highlighted Leaders in the Field